최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of hepatology : the journal of the European Association for the Study of the Liver, v.26 no.2, 1997년, pp.382 - 386
Safka, V. (Laboratoire d'Hemodynamique Splanchnique, Unite de Recherches de Physiopathologie Hepatique, INSERM U-24, Hopital Beaujon, ,, Clichy, France) , Moreau, R. , Gadano, A. , Lebrec, D.
Background/Aims: In cirrhosis, the activation of nitric oxide and prostacyclin contributes to vasolidation, and ATP-sensitive K+ (KATP) channel activation or L-type calcium (Ca2+) channel inhibition may also play a role in this process. At the same time in cirrhosis, certain endogenous mechanisms ma...
J Hepatol Moreau 22 370 1995 10.1016/0168-8278(95)80292-4 Endogenous factors involved in the control of arterial tone in cirrhosis
FASEB J Lincoln 7 328 1993 10.1096/fasebj.7.2.7680013 Intracellular cyclic GMP receptor proteins
Gastroenterology Ferraz 108 1183 1995 10.1016/0016-5085(95)90218-X Impaired vasodilatory responses in the gastric microcirculation of anesthesized rats with secondary biliary cirrhosis
Circulation Harrisson 87 1461 1993 10.1161/01.CIR.87.5.1461 The nitrovasodilators. New ideas about old drugs
Gastroenterology Moreau 106 1016 1994 10.1016/0016-5085(94)90762-5 Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis
Pharmacol Rev Spedding 44 363 1992 Classification of calcium channels and the sites of action of drugs modifying channel function
Am J Physiol Lee 251 G176 1986 Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium
Br J Exp Pathol Kountouras 65 305 1984 Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat
J Hepatol Hartleb 22 202 1995 10.1016/0168-8278(95)80430-7 Lack of vascular hyporesponsiveness to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis
Circ Res Wallenstein 47 1 1980 10.1161/01.RES.47.1.1 Some statistical methods useful in circulation research
J Hepatol Moreau 10 263 1990 10.1016/0168-8278(90)90129-F Nitrovasodilators and portal hypertension
Eur J Pharmacol Michielsen 273 67 1995 10.1016/0014-2999(94)00691-Y Role of nitric oxide in hyporeactivity to noradrenaline of isolated aortic rings in portal hypertensive rats
Hepatology Caimail 22 258A 1995 10.1016/0270-9139(95)94757-4 The role of calcium channels in in vitro vascular hyporeactivity to endothelin-1 (ET-1) in rats with cirrhosis
Hepatology Mathie 23 130 1996 10.1002/hep.510230118 Mesenteric vasodilator responses in cirrhotic rats: A role for nitric oxide?
Am J Pathol Albillos 268 G459 1995 Enhanced endothelium-dependent vasodilation in patients with cirrhosis
Hepatology Claria 20 1615 1994 10.1002/hep.1840200635 Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites
Hepatology Oberti 18 621 1993 10.1002/hep.1840180322 Role of prostacyclin in hemodynamic alterations in conscious rats with extra- or intra-hepatic portal hypertension
J Clin Invest Cahill 93 2691 1994 10.1172/JCI117283 Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits
Clin Pharmacol Ther Koshy 42 295 1987 10.1038/clpt.1987.150 Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosis
Hepatology Navasa 8 850 1988 10.1002/hep.1840080425 Effect of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension
Clin Pharmacol Ther Avagnina 53 368 1993 10.1038/clpt.1993.34 Effects of nifedipine on functional liver plasma flow in normal subjects and in patients with cirrhosis
J Gastroenterol Hepatol Ota 10 198 1995 10.1111/j.1440-1746.1995.tb01078.x Effects of nifedipine on hepatic venous pressure gradient and portal vein blood flow in patients with cirrhosis
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.